Wednesday, November 25, 2015

Molecular Therapy - Table of Contents alert Volume 23 Issue 11

If you are unable to see the message below, click here to view.
Molecular Therapy

TABLE OF CONTENTS

Volume 23, Issue 11 (November 2015)

In this issue
Editorial
In This Issue
Research Highlights
Commentary
Original Articles
Erratum
Corrigendum

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Molecular Therapy - Nucleic Acids is an online-only, open access journal publishing high quality basic, translational, and clinical research and cutting-edge reviews and commentaries targeted to the advances in oligonucleotide - and gene-based therapies. The journal has an Impact Factor of 4.512.

Explore the benefits of submitting your next research article: http://bit.ly/1vUsltu
 

Editorial

Top

Adeno-associated Vector Toxicity—To Be or Not to Be?

Hildegard Büning and Manfred Schmidt

Mol Ther 2015 23: 1673-1675; 10.1038/mt.2015.182

Full Text

In This Issue

Top

In This Issue

Mol Ther 2015 23: 1676; 10.1038/mt.2015.183

Full Text

Research Highlights

Top

Research Highlights

Mol Ther 2015 23: 1677; 10.1038/mt.2015.184

Full Text

Commentary

Top

Gene Editing and Germ-line Intervention: The Need for Novel Responses to Novel Technologies

Courtney Addison and Samuel Taylor-Alexander

Mol Ther 2015 23: 1678-1680; 10.1038/mt.2015.185

Full Text

Original Articles

Top

Long-term Improvements in Lifespan and Pathology in CNS and PNS After BMT Plus One Intravenous Injection of AAVrh10-GALC in Twitcher Mice

Mohammad A Rafi, Han Zhi Rao, Paola Luzi and David A Wenger

Mol Ther 2015 23: 1681-1690; advance online publication, September 2, 2015; 10.1038/mt.2015.145

Abstract | Full Text

Intracisternal Gtf2i Gene Therapy Ameliorates Deficits in Cognition and Synaptic Plasticity of a Mouse Model of Williams–Beuren Syndrome

Cristina Borralleras, Ignasi Sahun, Luis A Pérez-Jurado and Victoria Campuzano

Mol Ther 2015 23: 1691-1699; advance online publication, July 28, 2015; 10.1038/mt.2015.130

Abstract | Full Text

Pharmacological Modulation of Photoreceptor Outer Segment Degradation in a Human iPS Cell Model of Inherited Macular Degeneration

Ruchira Singh, David Kuai, Karina E Guziewicz, Jackelyn Meyer, Molly Wilson, Jianfeng Lu, Molly Smith, Eric Clark, Amelia Verhoeven, Gustavo D Aguirre and David M Gamm

Mol Ther 2015 23: 1700-1711; advance online publication, August 24, 2015; 10.1038/mt.2015.141

Abstract | Full Text

AAV2/1 CD74 Gene Transfer Reduces β-amyloidosis and Improves Learning and Memory in a Mouse Model of Alzheimer’s DiseaseMTOPEN

Tomomi Kiyota, Gang Zhang, Christine M Morrison, Megan E Bosch, Robert A Weir, Yaman Lu, Weiguo Dong and Howard E Gendelman

Mol Ther 2015 23: 1712-1721; advance online publication, July 31, 2015; 10.1038/mt.2015.142

Abstract | Full Text

A HER2-specific Modified Fc Fragment (Fcab) Induces Antitumor Effects Through Degradation of HER2 and ApoptosisMTOPEN

Kin-Mei Leung, Sarah Batey, Robert Rowlands, Samine J Isaac, Phil Jones, Victoria Drewett, Joana Carvalho, Miguel Gaspar, Sarah Weller, Melanie Medcalf, Mateusz M Wydro, Robert Pegram, Geert C Mudde, Anton Bauer, Kevin Moulder, Max Woisetschläger, Mihriban Tuna, John S Haurum and Haijun Sun

Mol Ther 2015 23: 1722-1733; advance online publication, August 3, 2015; 10.1038/mt.2015.127

Abstract | Full Text

A Lentiviral Vector Allowing Physiologically Regulated Membrane-anchored and Secreted Antibody Expression Depending on B-cell Maturation Status

Floriane Fusil, Sara Calattini, Fouzia Amirache, Jimmy Mancip, Caroline Costa, Justin B Robbins, Florian Douam, Dimitri Lavillette, Mansun Law, Thierry Defrance, Els Verhoeyen and François-Loïc Cosset

Mol Ther 2015 23: 1734-1747; advance online publication, August 18, 2015; 10.1038/mt.2015.148

Abstract | Full Text

miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma

Heba W Z Khella, Henriett Butz, Qiang Ding, Fabio Rotondo, Kenneth R Evans, Peter Kupchak, Moyez Dharsee, Ashraf Latif, Maria D Pasic, Evi Lianidou, Georg A Bjarnason and George M Yousef

Mol Ther 2015 23: 1748-1758; advance online publication, July 23, 2015; 10.1038/mt.2015.129

Abstract | Full Text

Huntingtin Haplotypes Provide Prioritized Target Panels for Allele-specific Silencing in Huntington Disease Patients of European Ancestry

Chris Kay, Jennifer A Collins, Niels H Skotte, Amber L Southwell, Simon C Warby, Nicholas S Caron, Crystal N Doty, Betty Nguyen, Annamaria Griguoli, Colin J Ross, Ferdinando Squitieri and Michael R Hayden

Mol Ther 2015 23: 1759-1771; advance online publication, July 23, 2015; 10.1038/mt.2015.128

Abstract | Full Text

Delivery of siRNA Using CXCR4-targeted Nanoparticles Modulates Tumor Microenvironment and Achieves a Potent Antitumor Response in Liver Cancer

Jia-Yu Liu, Tsaiyu Chiang, Chun-Hung Liu, Guann-Gen Chern, Ts-Ting Lin, Dong-Yu Gao and Yunching Chen

Mol Ther 2015 23: 1772-1782; advance online publication, August 17, 2015; 10.1038/mt.2015.147

Abstract | Full Text

Suppression of IL-7-dependent Effector T-cell Expansion by Multipotent Adult Progenitor Cells and PGE2

James L Reading, Bart Vaes, Caroline Hull, Shereen Sabbah, Thomas Hayday, Nancy S Wang, Anthony DiPiero, Nicholas A Lehman, Jen M Taggart, Fiona Carty, Karen English, Jef Pinxteren, Robert Deans, Anthony E Ting and Timothy I M Tree

Mol Ther 2015 23: 1783-1793; advance online publication, July 28, 2015; 10.1038/mt.2015.131

Abstract | Full Text

Erratum

Top

Erratum to “A HER2-specific Modified Fc Fragment (Fcab) Induces Antitumor Effects Through Degradation of HER2 and Apoptosis”

Mol Ther 2015 23: 1794; 10.1038/mt.2015.163

Full Text

Corrigendum

Top

Corrigendum to “Disruption of KATP Channel Expression in Skeletal Muscle by Targeted Oligonucleotide Delivery Promotes Activity-linked Thermogenesis”

Mol Ther 2015 23: 1794; 10.1038/mt.2015.186

Full Text

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Molecular Therapy. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: